Rigel Pharmaceuticals INC
-$263.5M
Net Activity
Institutions Holding
148
Popularity Rank
#3578
Avg Weight
0.06%
Total Value
$434.1M
148 institutions currently hold RIGL, with 78 net buyers and 94 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
94
Net Buying Institutions
78
Top 5 by Value
+$304.0M
Total Buy Value
$255.5M
Total Sell Value
78
Net Buyers
94
Net Sellers
1
Filings (90d)
$88K
Total Est. Value
3K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Ali-Jackson Kamil | 2026-06-22 | $88K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Rigel Pharmaceuticals appointed Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer, effective July 1, 2026. Dr. Hannah resigned from the Board in connection with this appointment. She takes over from Lisa Rojkjaer, M.D., who left the role on June 25, 2026.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter